• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number 5MAXACE068KIT
Device Problems Break (1069); Device Damaged Prior to Use (2284)
Patient Problem No Patient Involvement (2645)
Event Date 01/10/2019
Event Type  malfunction  
Manufacturer Narrative
This device is available for return.A follow up mdr will be submitted upon completion of the device investigation.
 
Event Description
During preparation for a medical procedure using a penumbra system ace 68 hi-flow kit, the penumbra system ace 68 reperfusion catheter (ace68) was found to be broken at the proximal end upon removal from the kit packaging.The damage to the ace68 was found prior to use and therefore it was not used in the procedure.The procedure was completed using another ace68 from a new kit.
 
Event Description
During preparation for a medical procedure using a penumbra system ace 68 reperfusion catheter (ace68) from a penumbra system ace 68 hi-flow kit, and a penumbra system 3max reperfusion catheter, the ace68 was found to be broken at the proximal end upon removal from the kit packaging.The damage to the ace68 was found prior to use and, therefore, it was not used in the procedure.The physician then began using a 3maxc and another ace68 from a new kit to continue the procedure.A report was received on 07-mar-2019 which indicated that after advancement of the ace68 over the 3maxc into the m1 segment of the middle cerebral artery (mca), the physician retracted the 3maxc to remove it and reported that the proximal part of the catheter broke as it was passing through the rotating hemostasis valve (rhv).The 3maxc was then completely removed and the procedure was completed successfully using the same ace68.There was no report of an adverse effect to the patient.
 
Manufacturer Narrative
Results: the ace68 was fractured approximately 57.5 cm from the hub.Conclusions: evaluation of the returned ace68 confirmed a fracture.If the device is retracted out of its packaging tray without removing the top portion of the tray, the ace68 may become wedged between the two trays and result in a fracture.Evaluation of the returned 3maxc confirmed a fracture.If the device was forcefully retracted through a tightened rhv or at an extreme angle through the rhv, damage such as a fracture may occur.Penumbra catheters are visually inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
MDR Report Key8356622
MDR Text Key136743531
Report Number3005168196-2019-00305
Device Sequence Number1
Product Code NRY
UDI-Device Identifier00814548016603
UDI-Public00814548016603
Combination Product (y/n)Y
PMA/PMN Number
K161640
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/01/2005,01/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/21/2021
Device Catalogue Number5MAXACE068KIT
Device Lot NumberF85406
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/28/2019
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received03/07/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-